Sign in

CIK 0001799448

  • Non-accelerated filer
  • Smaller reporting company

Aligos Therapeutics, Inc.

Sign in to watch
Ticker
ALGS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 800-466-6059
Business address
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-09 BLATT LAWRENCE President and CEO Grant or award · Stock Option (Right to Buy) +105,840 105,840
2025-07-16 BLATT LAWRENCE President and CEO Grant or award · Stock Option (Right to Buy) +179,800 179,800
2025-02-28 BLATT LAWRENCE President and CEO Grant or award · Stock Option (Right to Buy) +140,103 140,103
2024-09-04 BLATT LAWRENCE Chief Executive Officer Grant or award · Stock Option (Right to Buy) +33,920 33,920
2024-03-01 BLATT LAWRENCE Chief Executive Officer Grant or award · Stock Option (Right to Buy) +965,435 965,435
2024-02-28 BLATT LAWRENCE Chief Executive Officer Grant or award · Stock Option (Right to Buy) +132,352 132,352
2024-02-28 BLATT LAWRENCE Chief Executive Officer Grant or award · Stock Option (Right to Buy) +230,999 230,999
2024-02-28 BLATT LAWRENCE Chief Executive Officer Grant or award · Stock Option (Right to Buy) +57,749 57,749
2024-02-27 BLATT LAWRENCE Chief Executive Officer Returned to the company · Stock Option (Right to Buy) −450,000 0
2024-02-27 BLATT LAWRENCE Chief Executive Officer Returned to the company · Stock Option (Right to Buy) −323,400 0
2024-02-27 BLATT LAWRENCE Chief Executive Officer Returned to the company · Stock Option (Right to Buy) −80,850 0
2023-10-25 BLATT LAWRENCE Chief Executive Officer Grant or award +610,277 $0.76 $462K 1,847,575
2023-10-25 BLATT LAWRENCE Chief Executive Officer Grant or award · Warrants (Right to Buy) +305,138 $0.13 $38K 305,138
2023-09-08 BLATT LAWRENCE Chief Executive Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000
2023-03-15 BLATT LAWRENCE Chief Executive Officer Grant or award · Stock Option (Right to Buy) +242,500 242,500
2022-07-07 BLATT LAWRENCE Chief Executive Officer Grant or award · Stock Option (Right to Buy) +161,700 161,700
2022-02-04 BLATT LAWRENCE Chief Executive Officer Grant or award · Stock Option (Right to Buy) +323,400 323,400
2022-02-04 BLATT LAWRENCE Chief Executive Officer Grant or award · Stock Option (Right to Buy) +80,850 80,850
2020-12-01 BLATT LAWRENCE Chief Executive Officer Grant or award · Stock Option (Right to Buy) +450,000 450,000
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +41,016 41,016

Page 1 of 2 · 39 trades